<qa>  What is the name of the abnormalities that interfere with the patients participation in this study- Any clinically significant laboratory abnormalities which, in the judgment of the investigator, would interfere with the patients participation in this study or evaluation of study results liver transaminases and bilirubin must be within normal limits. 